Lung Cancer Clinical Trials

Find Lung Cancer Clinical Trials Near You

Label-free Femtosecond Laser Imaging Combined With the Fast Lung Artificial Intelligence Model for Rapid Intraoperative Diagnosis of Lung Surgical Specimens: A Multicentre, Prospective, Parallel-workflow, Non-inferiority Study.

Status: Recruiting
Location: See all (5) locations...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

This study aims to evaluate whether femtosecond laser imaging combined with FastLung AI model can provide intraoperative diagnostic performance that is non-inferior to standard frozen section diagnosis for pulmonary nodules or suspected pulmonary tumor lesions. Patients scheduled for lung surgery and requiring intraoperative pathological assessment will be prospectively enrolled. After tumor excision, the fresh tumor specimen will be bisected through the central plane. One half will be used for standard frozen section diagnosis, and the mirrored counterpart will be used for femtosecond laser imaging. Both diagnostic results will be compared with the final paraffin-embedded pathological diagnosis as the reference standard. The results of femtosecond laser imaging will not guide intraoperative clinical decision-making.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 90
Healthy Volunteers: f
View:

• Preoperative imaging suggests a pulmonary nodule, pulmonary space-occupying lesion, or suspected pulmonary tumor lesion.

• The participant is scheduled to undergo pulmonary wedge resection, segmentectomy, lobectomy, or other pulmonary surgery.

• Fresh lung tissue specimens can be obtained intraoperatively for femtosecond laser imaging.

• Intraoperative frozen section diagnosis is planned to assess the nature of the tumor lesion.

• Corresponding postoperative paraffin-embedded pathological diagnosis can be obtained.

• The participant or the participant's legally authorized representative has signed the written informed consent form.

• Patients had not received any antitumor treatment prior to enrollment or specimen collection, including chemotherapy, radiotherapy, targeted therapy, immunotherapy, or other systemic anticancer treatments.

Locations
Other Locations
China
Dongfang Hospital
NOT_YET_RECRUITING
Shanghai
Huadong Hospital
NOT_YET_RECRUITING
Shanghai
Shanghai Chest Hospital
RECRUITING
Shanghai
Tongji Hospital
NOT_YET_RECRUITING
Shanghai
Tongren Hospital
NOT_YET_RECRUITING
Shanghai
Contact Information
Primary
Xinghua Cheng, Dr. PhD.
xinhuacheng@sjtu.edu.cn
17701681215
Time Frame
Start Date: 2026-07-03
Estimated Completion Date: 2026-11-30
Participants
Target number of participants: 294
Treatments
Patients undergoing intraoperative pulmonary nodule diagnosis
Patients with pulmonary nodules who are scheduled for surgical resection and require intraoperative pathological assessment. All participants will undergo femtosecond laser imaging and standard frozen section diagnosis in parallel, and both results will be compared with final paraffin pathology as the reference standard.
Related Therapeutic Areas
Sponsors
Leads: Shanghai Chest Hospital
Collaborators: Femtosecond Applications and Research (Guangzhou)

This content was sourced from clinicaltrials.gov